These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6141285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE, Wahl RA, Branscheid D, Roeher HD.
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP, Allred SJ.
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [Abstract] [Full Text] [Related]

  • 6. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.
    Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL.
    N Engl J Med; 1990 Jun 21; 322(25):1764-8. PubMed ID: 1971708
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G, Gries J, Hofmann HP, Kreiskott H, Kretzschmar R, Müller CD, Raschack M, Teschendorf HJ.
    Arzneimittelforschung; 1984 Jun 21; 34(11):1489-97. PubMed ID: 6543124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL, Seidler FJ, Slotkin TA.
    J Mol Cell Cardiol; 1997 Feb 21; 29(2):603-15. PubMed ID: 9140819
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K, Schnecko A, Hauth D, Wirzius S, Lemmer B.
    Br J Pharmacol; 1998 Nov 21; 125(5):1033-41. PubMed ID: 9846642
    [Abstract] [Full Text] [Related]

  • 11. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
    Stoschitzky K, Klein W, Stark G, Stark U, Zernig G, Graziadei I, Lindner W.
    Clin Pharmacol Ther; 1990 Jun 21; 47(6):740-6. PubMed ID: 2162749
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacological studies on alterations in myocardial beta-adrenoceptors and their intracellular signal transduction in experimental diabetic rats].
    Gando S.
    Hokkaido Igaku Zasshi; 1994 Sep 21; 69(5):1140-53. PubMed ID: 7868054
    [Abstract] [Full Text] [Related]

  • 13. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K, Pedone C, Brooker G.
    Mol Pharmacol; 1984 Mar 21; 25(2):256-60. PubMed ID: 6321948
    [Abstract] [Full Text] [Related]

  • 14. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO, Derkach KV, Uspenskaia ZI, Shpakova EA, Kuznetsova LA, Plesneva SA, Pertseva MN.
    Tsitologiia; 2004 Mar 21; 46(4):317-25. PubMed ID: 15346790
    [Abstract] [Full Text] [Related]

  • 15. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F, Mantelli L.
    G Ital Cardiol; 1984 Apr 21; 14(4):279-84. PubMed ID: 6329868
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
    Persad S, Takeda S, Panagia V, Dhalla NS.
    J Mol Cell Cardiol; 1997 Feb 21; 29(2):545-58. PubMed ID: 9140814
    [Abstract] [Full Text] [Related]

  • 17. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M.
    J Pharmacol Exp Ther; 1997 Jul 21; 282(1):475-84. PubMed ID: 9223590
    [Abstract] [Full Text] [Related]

  • 18. Clinical pharmacology and beta-blocking efficacy of propafenone.
    Barbey JT.
    J Cardiovasc Pharmacol; 1991 Jul 21; 17 Suppl 6():S41-3. PubMed ID: 1723117
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
    Wagner F, Jähnchen E, Trenk D.
    Eur J Clin Pharmacol; 1989 Jul 21; 36(6):579-82. PubMed ID: 2570700
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
    Nanoff C, Schütz W.
    J Cardiovasc Pharmacol; 1991 Dec 21; 18(6):837-42. PubMed ID: 1725895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.